J5 Acquisition Corp. Announces Results of Shareholder Meeting



TORONTO, April 15 /CNW/ - Further to the press releases dated February 15, 2011 and March 2, 2011, J5 Acquisition Corp. ("J5") announces, in connection with the previously announced qualifying transaction with Trimel BioPharma Holdings Inc. (the "Qualifying Transaction"), that it has received shareholder approval for all of the resolutions set forth in J5's management information circular dated March 16, 2011 which circular is posted on SEDAR.

Completion of the Qualifying Transaction is subject to a number of conditions including, but not limited to, regulatory approvals and TSX Venture Exchange acceptance. There can be no assurance that the Qualifying Transaction will be completed as proposed or at all.

Investors are cautioned that, except as disclosed in the non-offering prospectus to be prepared in connection with the Qualifying Transaction, any information released or received with respect to the Qualifying Transaction may not be accurate or complete and should not be relied upon.

Investors are cautioned that trading in the securities of a CPC should be considered highly speculative.

J5 is a CPC governed by the policies of the TSX Venture Exchange.  J5's principal business is the identification and evaluation of assets or businesses with a view to completing a Qualifying Transaction.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE J5 Acquisition Corp.

For further information:

Ron D. Schmeichel, Chief Executive Officer of J5, at (416) 972-6294

Organization Profile

J5 Acquisition Corp.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890